🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cognitive Evaluation of Patients With Eating Disorders

Recruitingn/aAges 14 Years - 65 YearsAllIstituti Clinici Scientifici Maugeri SpA
NCT07478510 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this cross - sectional observational study is to improve understanding of the psychological and cognitive characteristics of Feeding and Eating Disorders (FEDs), a group of conditions that represent a growing public health concern due to their significant impact on physical health, emotional well-being, and everyday functioning. Within this broader diagnostic category, particular attention is given to Avoidant/Restrictive Food Intake Disorder (ARFID), a diagnosis introduced in the DSM-5 and still relatively underexplored compared to other feeding and eating disorders. Despite its clinical relevance, ARFID remains less well understood in terms of its underlying cognitive and psychological mechanisms. Individuals with ARFID often experience severe food avoidance or restriction that is not driven by weight or shape concerns, but rather by sensory sensitivities, fear of negative

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of a Feeding and Eating Disorder (ARFID, anorexia nervosa, or bulimia nervosa); * Patients of both sexes; * Age between 14 and 65 years; * Confirmed diagnosis of a Feeding and Eating Disorder; * Body Mass Index (BMI) \< 25; * Signed informed consent form for participation in the study. Exclusion Criteria: * Diagnosis of Bipolar Disorder according to DSM-5-TR criteria; * Diagnosis of a Schizophrenia Spectrum Disorder according to DSM-5-TR criteria; * Intellectual disability according to DSM-5-TR criteria; * Presence of brain tumors; * History of seizure events; * Presence of other moderate to severe neurological disorders; * Lack of the patient's consent to voluntary participation in the study; * Lack of parental or legal guardian consent for participation of a minor in the study.
💊

What it tests

  • Go/No-go
  • IAT
  • WCST
📍

Where

3 sites
IUSS Pavia - Istituto Universitario di Studi Superiori
Pavia, Italy
Istituto Psicologico Italiano s.r.l.s.
Milan, Italy
ASST Fatebenefratelli Sacco
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy